EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes

Berta Caballol iD, Ingrid Ordás, Carolina Saavedra, Julia Saidman, Maria Carmen Masamunt, Marta Gallego, Rebeca Barastegui, Agnès Fernández-Clotet iD, Alex Menys, Julian Panés iD, Elena Ricart, Jordi Rimola

United European Gastroenterology Journal · 2025-09 · 13 (7) · 1217-1225

DOI: 10.1002/ueg2.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift United European Gastroenterology Journal, online erschienen am 18.07.2025. Verfasst von Berta Caballol und 11 weiteren Autor:innen. Beteiligte Einrichtung: IBD Unit, Gastroenterology Department, Hospital Clinic de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Crohn Disease, Rectal Fistula, Magnetic Resonance Imaging. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EU Commission, Leona M. and Harry B. Helmsley Charitable Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Changes in 3D volumetry of perianal fistulas in patients with Crohn's disease (CD) measured by MRI could be an imaging biomarker of interest. The objective of the study was to determine the value of volumetric changes in CD perianal fistulas after medical treatment to predict outcomes.

Methods

This is a retrospective single‐center pilot study evaluating CD patients with active perianal fistulas who started biological therapy between 2012 and 2021. Eligible patients were those who had both pre‐ and post‐treatment pelvic MRI and clinical follow‐up of 2–5 years. Patients were categorized as clinically active or in remission based on fistula drainage. Using specific software, we calculated the 3D volume of the fistulas, and their active and fibrotic components. We evaluated MRI volumetric changes between assessments and analyzed their predictive value for clinical remission.

Results

We included 24 patients (83.3% with complex fistulas), of which 13 were in clinical remission at the last follow‐up. Logistic regression analysis identified the percentage of relative change in the volumetric active component as an independent predictor of clinical remission (OR 0.92 [0.86–0.98] p = 0.013). The area under receiver operating characteristic (ROC) curve was 85.3% ( p < 0.0001). A reduction of ≥ 16% in the volumetric percentage of the active component has a sensitivity of 84.6 and specificity of 81% in predicting clinical remission during follow‐up.

Conclusion

Changes in the 3D MRI volumetry of perianal fistulas might have value in predicting clinical remission. Specifically, the reduction in the volumetry of the active component emerges as a promising biomarker for assessing therapeutic response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseRectal FistulaMagnetic Resonance ImagingHumansFemaleMaleAdultRetrospective StudiesPilot ProjectsMiddle AgedPredictive Value of TestsBiomarkersTreatment OutcomeImaging, Three-DimensionalRemission InductionROC CurveFeasibility StudiesFollow-Up StudiesYoung Adult

Stichwörter der Autor:innen

MRIbiological treatmentbiologicsfistulaimagingmedicalpelvicpredictionremissionvolume

Substanzen

Biomarkers

Autor:innen und Institutionen

  • IBD Unit, Gastroenterology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Motilent Limited, London, UK.
  • IBD Unit, Radiology Department, Hospital Clinic de Barcelona, Barcelona, Spain.

ORCID-Profile: Berta Caballol, Agnès Fernández-Clotet, Julian Panés

Förderung

  • EU Commission
  • Leona M. and Harry B. Helmsley Charitable Trust

Zitieren

APA

Caballol, B., Ordás, I., Saavedra, C., Saidman, J., Masamunt, M. C., Gallego, M., Barastegui, R., Fernández-Clotet, A., Menys, A., Panés, J., Ricart, E., & Rimola, J. (2025). Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes. United European Gastroenterology Journal, 13(7), 1217-1225. https://doi.org/10.1002/ueg2.70003

Vancouver

Caballol B, Ordás I, Saavedra C, Saidman J, Masamunt MC, Gallego M, et al. Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes. United European Gastroenterology Journal. 2025;13(7):1217-1225. doi:10.1002/ueg2.70003

BibTeX
@article{Caballol2025,
  author = {Caballol, Berta and Ordás, Ingrid and Saavedra, Carolina and Saidman, Julia and Masamunt, Maria Carmen and Gallego, Marta and Barastegui, Rebeca and Fernández-Clotet, Agnès and Menys, Alex and Panés, Julian and Ricart, Elena and Rimola, Jordi},
  title = {Volumetric Changes in Perianal Fistulizing Crohn's Disease Measured by Magnetic Resonance Is Feasible and Could Be a Potential Biomarker to Predict Clinical Outcomes},
  journal = {United European Gastroenterology Journal},
  year = {2025},
  volume = {13},
  number = {7},
  pages = {1217--1225},
  doi = {10.1002/ueg2.70003}
}
Kostenlos starten →